WAGNER CHARLES F JR 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Dec 5, 2025
Insider Transaction Report
Form 4
WAGNER CHARLES F JR
EVP, CO & FO
Transactions
- Sale
Common Stock
[F1]2025-12-03$451.00/sh−7,000$3,157,000→ 44,725 total - Sale
Common Stock
[F1]2025-12-03$461.00/sh−7,000$3,227,000→ 37,725 total
Footnotes (1)
- [F1]Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 5/9/2025.
Signature
/s/ Christiana Stevenson, Attorney-in-Fact|2025-12-05